Facebook Twitter

This California man who got the Johnson & Johnson vaccine was hospitalized with a blood clot

Can the blood clot symptom happen to men? For one California man, it did

SHARE This California man who got the Johnson & Johnson vaccine was hospitalized with a blood clot
Syringes full of the Johnson & Johnson COVID-19 vaccine await patients during a drive-thru vaccination clinic.

Syringes full of the Johnson & Johnson COVID-19 vaccine await patients during a drive-thru vaccination clinic at Intermountain Healthcare’s The Orthopedic Specialty Hospital in Murray on Thursday, March 4, 2021.

Spenser Heaps, Deseret News

The Johnson & Johnson COVID-19 vaccine was recently paused by federal officials after reports of blood clots among women who got the vaccine, raising questions about the safety of the vaccine. But a week and a half after the pause began, federal officials allowed the rollout of the vaccine to resume again.

  • However, days later, there are reports of someone suffering blood clots after getting the vaccine. And, unlike the reports from the federal government, the patient was a man.

Did a California man get blood clots from J&J vaccine?

A California man is now under care at the University of California San Francisco medical center because he suffered blood clotting after getting the Johnson & Johnson COVID-19 vaccine, Fox News reports.

  • “To the best of our knowledge, this is the first male patient with VITT (vaccine-induced thrombotic thrombocytopenia) syndrome in the U.S. following the U.S. emergency authorization of the Johnson & Johnson vaccine on Feb. 27, 2021,” UCSF spokeswoman Suzanne Leigh said in a statement to Fox News.
  • The patient is reportedly in his 30s and “is making a good recovery and is expected to be discharged within a few days,” Leigh told Fox News.

According to the San Francisco Chronicle, the patient discovered the blood clot in his leg one week after he received the Johnson & Johnson vaccine.

Should you be worried about the Johnson & Johnson vaccine?

The Centers for Disease Control and Prevention and Food and Drug Administration announced late last week that the Johnson & Johnson vaccine’s pause was over, and that people could start receiving the vaccine, as I wrote for the Deseret News.

  • Federal officials said a label warning for blood clots would be added to the vaccine.
  • The original pause came after six women reported suffering blood clots after getting the vaccine.

Dr. Rochelle Walensky, the CDC director, said that the CDC will continue to monitor the vaccine to see if more side effects pop up. But for now, it’s safe to resume and accept the vaccine, as I wrote for theDeseret News.

  • “As we always do, we will continue to watch all signals closely as more Americans are vaccinated,” Walensky said. “I continue to be encouraged by the growing body of real-world evidence that the authorized COVID-19 vaccines are safe and effective, and they protect people from disease, hospitalization, and death. I urge anyone with questions about the COVID-19 vaccines to speak with their healthcare provider or local public health department.”